Pierre-Alexandre Bart

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


153 publications

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1996 | 1995 |
2024
Mental health and burnout during medical school: Longitudinal evolution and covariates
Carrard Valerie, Berney Sylvie, Bourquin Céline, Ranjbar Setareh, Castelao Enrique, Schlegel Katja, Gaume Jacques, Bart Pierre-Alexandre, Schmid Mast Marianne, Preisig Martin et al., 2024/04/16. PLOS ONE, 19 (4) pp. e0295100. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE638253A8B9]
 
Outcome of severe COVID-19: spotlight on fatigue, fatigability, multidomain complaints and pattern of cognitive deficits in a case series without prior brain dysfunction and without COVID-19-related stroke and/or cardiac arrest.
Beaud V., Crottaz-Herbette S., Dunet V., Knebel J.F., Bart P.A., Clarke S., 2024/02/02. Journal of medical case reports, 18 (1) p. 64. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DA2044CF76D3]
2023
 
L’hôpital aussi se préoccupe des coûts de la santé.
Bart P.A., 2023/12/13. Revue medicale suisse, 19 (854) p. 2375. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_860BF285230B]
 
Le cœur qui lâche ? Le fer peu efficace.
Simonin M., Bart P.A., 2023/12/06. Revue medicale suisse, 19 (853) p. 2323. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_503B2941A757]
 
Quand suspecter une immunodéficience chez le patient hospitalisé en médecine interne? [Should we suspect immune deficiency in internal medicine hospitalized patients?]
Gerber C., Bart P.A., Comte D., 2023/11/22. Revue medicale suisse, 19 (851) pp. 2200-2205. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9B00B380EB31]
 
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.
Global Tuberculosis Network and TB/COVID-19 Global Study Group, Casco N., Jorge A.L., Palmero D.J., Alffenaar J.W., Fox G.J., Ezz W., Cho J.G., Denholm J., Skrahina A. et al., 2023/11. The European respiratory journal, 62 (5) p. 2300925. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C73E5F757E12]
 
Pneumonies communautaires sévères : utilité des corticostéroïdes.
Bart P.A., 2023/05/31. Revue medicale suisse, 19 (829) pp. 1110-1111. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_29599D507B0F]
 
Vaccins contre le RSV: nouveaux arrivants – après SARS-CoV-2 – sur la scène des vaccins.
Bart P.A., 2023/05/10. Revue medicale suisse, 19 (826) p. 923. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_44E440056731]
Remodelling family medicine teaching at the University of Lausanne using a modified Delphi method.
Pedrazzini B., Boulet M.C., Héritier F., Bart P.A., Senn N., 2023/04/17. Swiss medical weekly, 153 (4) p. 40064. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EB84AD82053]
 
O.18.2 - How different dimensions of medical students’ empathy relate to mental health and burnout: Presenter(s): Alexandre Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland; Sylvie Berney, Lausanne University Hospital (CHUV) and University of Lausanne, Switzerland
Carrard Valerie, Schlegel Katja, Gauma Jacques, Bart Pierre-Alexandre, Preisig Martin, Schmid Mast Marianne, Bourquin Céline, 2023/04/01. Patient Education and Counseling. Peer-reviewed.
[serval:BIB_51A34757A3D1]
 
Antagonistes des récepteurs de l’endothéline : bénéfiques dans l’HTAP certes, mais dans l’HTA aussi ?
Bart P.A., 2023/02/22. Revue medicale suisse, 19 (815) p. 391. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_089AF9800B74]
2022
 
Comparison of Nasopharyngeal and Saliva Swab Nucleic Acid Amplification and Rapid Antigen Testing To Detect Omicron SARS-CoV-2 Variant of Concern: a Prospective Clinical Trial (OMICRON).
Kritikos A., Caruana G., Lazor-Blanchet C., Currat M., Chiche J.D., Vollenweider P., Bart P.A., Opota O., Greub G., 2022/12/21. Microbiology spectrum, 10 (6) pp. e0392322. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6A6FC8A196FD]
The relationship between medical students' empathy, mental health, and burnout: A cross-sectional study.
Carrard V., Bourquin C., Berney S., Schlegel K., Gaume J., Bart P.A., Preisig M., Schmid Mast M., Berney A., 2022/12. Medical teacher, 44 (12) pp. 1392-1399. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_601B999D0EBE]
 
Les ACOD ? Pas forcément bons à tout faire.
Bart P.A., 2022/11/30. Revue medicale suisse, 18 (806) p. 2307. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F5F85957531E]
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.
Hepprich M., Mudry J.M., Gregoriano C., Jornayvaz F.R., Carballo S., Wojtusciszyn A., Bart P.A., Chiche J.D., Fischli S., Baumgartner T. et al., 2022/11. EClinicalMedicine, 53 p. 101649. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9319C60420A1]
COVID-19 rapidly increases MDSCs and prolongs innate immune dysfunctions.
Schrijver I.T., Théroude C., Antonakos N., Regina J., Le Roy D., Bart P.A., Chiche J.D., Perreau M., Pantaleo G., Calandra T. et al., 2022/10. European journal of immunology, 52 (10) pp. 1676-1679. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CE51282F926C]
Vaut-il la peine de vacciner contre SARS-CoV-2 les patients ayant reçu des thérapies anti-CD20 ? Oui, mais à certaines conditions.
Bart P.A., 2022/03/16. Revue medicale suisse, 18 (773) p. 499. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_B443AF8994A7]
Stopper les IECA et les ARA au début d’une infection par SARS-CoV-2 : une décision au cas par cas.
Bart P.A., 2022/01/19. Revue medicale suisse, 18 (764-5) p. 91. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DDB62350BDD8]
Iberogast®-Induced Acute Liver Injury—A Case Report
Leroy A., Perrin H., Porret R., Sempoux C., Chtioui H., Fraga M., Bart PA, 2022. Gastro Hep Advances, 1 (4) pp. 601-603.
[URN][DOI][serval:BIB_5E2F0FB82317]
 
Racisme et pratique de la médecine : éléments pour un apprentissage nécessaire
Bodenmann Patrick, Hrasnica Farah, Prod'hom Dimitri, Perrin Ève Marie, Ishii Alessandro, Porret Raphaël, Fricker Cédric, Morisod Kevin, Sanchis Zozaya Javier, Malebranche Mary et al., 2022. pp. 165-177 dans Bodenmann Patrick, Jackson Yves, Vu Francis, Wolff Hans (eds.) Vulnérabilités, diversités et équité en santé chap. 1.14, RMS éditions / Médecine et Hygiène.
[serval:BIB_140A6A81D8C8]
Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis.
Cisarovsky C., Théaudin M., Bart P.A., Stalder G., Alberio L., 2022. Case reports in hematology, 2022 p. 2767031. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A48F4C0C1B5F]
2021
Study protocol for the ETMED-L project: longitudinal study of mental health and interpersonal competence of medical students in a Swiss university using a comprehensive framework of empathy.
Berney A., Carrard V., Berney S., Schlegel K., Gaume J., Gholam M., Bart P.A., Preisig M., Wac K., Schmid Mast M. et al., 2021/12/03. BMJ open, 11 (12) pp. e053070. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2C7AE28A4CF5]
 
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials.
Fischinger S., Cizmeci D., Deng D., Grant S.P., Frahm N., McElrath J., Fuchs J., Bart P.A., Pantaleo G., Keefer M. et al., 2021/11. PLoS pathogens, 17 (11) pp. e1010016. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1241293379B]
 
Sensitivity of Rapid Antigen Testing and RT-PCR Performed on Nasopharyngeal Swabs versus Saliva Samples in COVID-19 Hospitalized Patients: Results of a Prospective Comparative Trial (RESTART).
Kritikos A., Caruana G., Brouillet R., Miroz J.P., Abed-Maillard S., Stieger G., Opota O., Croxatto A., Vollenweider P., Bart P.A. et al., 2021/09/09. Microorganisms, 9 (9) p. 1910. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F1553D2BFA41]
Pattern of cognitive deficits in severe COVID-19.
Beaud V., Crottaz-Herbette S., Dunet V., Vaucher J., Bernard-Valnet R., Du Pasquier R., Bart P.A., Clarke S., 2021/05. Journal of neurology, neurosurgery, and psychiatry, 92 (5) pp. 567-568. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F33888332B52]
2020
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8BF1D4A9E075]
An Early Warning Score to predict ICU admission in COVID-19 positive patients.
Meylan S., Akrour R., Regina J., Bart P.A., Dami F., Calandra T., 2020/11. The Journal of infection, 81 (5) pp. 816-846. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A37D6F510D8C]
Racisme et pratique de la médecine : éléments pour un apprentissage nécessaire [Racism and the practice of medicine : elements for a required learning]
Bodenmann P., Hrasnica F., Prod'hom D., Perrin È.M., Ishii A., Porret R., Fricker C., Morisod K., Sanchis Zozaya J., Malebranche M.E. et al., 2020/07/15. Revue medicale suisse, 16 (700) pp. 1373-1379. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_51045F137D37]
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Tadolini M., Codecasa L.R., García-García J.M., Blanc F.X., Borisov S., Alffenaar J.W., Andréjak C., Bachez P., Bart P.A., Belilovski E. et al., 2020/07. The European respiratory journal, 56 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4A0EAE45C82A]
 
Does One Dose Really Fit All? On the Monitoring of Direct Oral Anticoagulants: A Review of the Literature.
Moner-Banet T., Alberio L., Bart P.A., 2020/06. Hamostaseologie, 40 (2) pp. 184-200. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_725BA4ED3F23]
 
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
Lévy Y., Lacabaratz C., Ellefsen-Lavoie K., Stöhr W., Lelièvre J.D., Bart P.A., Launay O., Weber J., Salzberger B., Wiedemann A. et al., 2020/06. PLoS pathogens, 16 (6) pp. e1008522. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82AFFC2A801F]
Étudiant·e·s en médecine engagé·e·s au chevet des patient·e·s hospitalisé·e·s pour COVID-19 - Motivations et enjeux [Medical students at the bedside of COVID-19 patients : motivations and challenges]
Aebischer O., Porret R., Pawlowska V., Barbier J., Caratsch L., Moreira De Jesus M., Castioni J., Kraege V., Bart P.A., Mean M. et al., 2020/05/06. Revue medicale suisse, 16 (692) pp. 958-961. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_806E91069FB3]
Impacts organisationnels et défis cliniques de la pandémie COVID-19 pour un service hospitalier de médecine interne universitaire [Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]
Garnier A., Vaucher J., Bianchi C., Kraege V., Méan M., Castioni J., Bart P.A., Champier V., Eggimann P., Gachoud D. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 869-874. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C4B18AADE722]
PROFILES: portrait-type de nos futurs médecins ! [PROFILES: typical portrait of the future Swiss doctors]
Bart P.A., Monti M., Gachoud D., Félix S., Turpin D., Marino L., Takeuchi Y.L., Senn N., Sohrmann M., 2020/01/22. Revue medicale suisse, 16 (678) pp. 133-137. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AD9A2E8336CF]
 
Epidemiology, risk factors and clinical course of SARS-CoV-2 infected patients in a Swiss university hospital: An observational retrospective study.
Regina J., Papadimitriou-Olivgeris M., Burger R., Le Pogam M.A., Niemi T., Filippidis P., Tschopp J., Desgranges F., Viala B., Kampouri E. et al., 2020. PloS one, 15 (11) pp. e0240781. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BE26AADAD401]
Predicting Venous Thromboembolic Events in Patients with Coronavirus Disease 2019 Requiring Hospitalization: an Observational Retrospective Study by the COVIDIC Initiative in a Swiss University Hospital.
Kampouri E., Filippidis P., Viala B., Méan M., Pantet O., Desgranges F., Tschopp J., Regina J., Karachalias E., Bianchi C. et al., 2020. BioMed research international, 2020 p. 9126148. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_458CAB0E5E15]
2019
Manifestations cutanées de carences nutritionnelles, ou quand l’examen de la peau alimente le diagnostic [Cutaneous manifestations of nutritional deficiencies]
Schlomer T., Di Lucca J., Bart P.A., 2019/11/20. Revue medicale suisse, 15 (672) pp. 2125-2130. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40B08058B916]
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
Pantaleo G., Janes H., Karuna S., Grant S., Ouedraogo G.L., Allen M., Tomaras G.D., Frahm N., Montefiori D.C., Ferrari G. et al., 2019/11. The lancet. HIV, 6 (11) pp. e737-e749. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0F89E125D865]
2018
 
Médecine et genre : quels enjeux pour la pratique ? [Medicine and gender : which challenges for clinical practice ?]
Clair C., Cornuz J., Bart P.A., Schwarz J., 2018/10/31. Revue medicale suisse, 14 (625) pp. 1951-1954. Peer-reviewed.
[Pmid][serval:BIB_E4018860569E]
2017
 
Dossier patient informatisé – belle opportunité de repenser l’information médicale et son utilisation [The electronic patient record - a great opportunity to rethink medical information and its use]
Bastardot F., Wasserfallen J.B., Regamey P.F., Bart P.A., 2017/11/22. Revue medicale suisse, 13 (584) pp. 2027-2030. Peer-reviewed.
[Pmid][serval:BIB_189B7396A9D1]
Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect™.
Vescovo P., Rettby N., Ramaniraka N., Liberman J., Hart K., Cachemaille A., Piveteau L.D., Zanoni R., Bart P.A., Pantaleo G., 2017/03/27. Vaccine, 35 (14) pp. 1782-1788. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A7C81D7FFA31]
 
Réponse []
Moschouri E., Bart P.A., 2017/02/08. Revue medicale suisse, 13 (549) p. 385. Peer-reviewed.
[Pmid][serval:BIB_19FC8338177A]
 
Hémoptysies à l’âge de 18 ans
Al Jarrah Saif, Bart Pierre Alexandre, Lazor Romain, Naccini Bruno, Castioni Julien, 2017. Swiss Med Forum, 17 (30-31) pp. 637-641.
[serval:BIB_EFB637E84D55]
2016
 
Evénements indésirables en médecine interne : du recueil d’événements au colloque morbidité-mortalité [From incident-reporting to morbidity and mortality rounds]
Kraege V., Chevaux F., Servet J., Bart P.A., Sartori C., Castioni J., 2016/11/23. Revue medicale suisse, 12 (540) pp. 2020-2025.
[Pmid][serval:BIB_86BEA5C25702]
 
Les autopsies médicales comme contrôle de qualité de la prise en charge des patients en médecine interne [The role of medical autopsies as a quality control of patients management in internal medicine units]
Rotman S., Zaugg T., Bart P.A., 2016/11/23. Revue medicale suisse, 12 (540) pp. 2015-2019. Peer-reviewed.
[Pmid][serval:BIB_2F86783F39B1]
 
Mon patient va recevoir une immunosuppression : quelles vaccinations pour quelle situation ? [My patient will receive immunosuppressive therapy : which vaccination for each situation ?]
Moschouri E., Bart P.A., 2016/11/23. Revue medicale suisse, 12 (540) pp. 1997-2002. Peer-reviewed.
[Pmid][serval:BIB_F59EBFE258A2]
Toux et hyperéosinophilie sévère chez une patiente de 80 ans [Cough and severe hypereosinophilia in an 80-years old lady]
Ghosn Jacqueline Thérèse, Bart Pierre-Alexandre, Brouland Jean-Philippe, Garnier Antoine, 2016/08/16. Forum Médical Suisse ‒ Swiss Medical Forum, 16 (33).
[URN][DOI][serval:BIB_997AF518DBD4]
 
IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation.
Fellmann F., Angelini F., Wassenberg J., Perreau M., Arenas Ramirez N., Simon G., Boyman O., Demaria O., Christen-Zaech S., Hohl D. et al., 2016. Journal of Allergy and Clinical Immunology, 137 (4) pp. 1189-96.e1-2. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D933D1DD0E0F]
2015
COMPASS identifies T-cell subsets correlated with clinical outcomes.
Lin L., Finak G., Ushey K., Seshadri C., Hawn T.R., Frahm N., Scriba T.J., Mahomed H., Hanekom W., Bart P.A. et al., 2015/06. Nature biotechnology, 33 (6) pp. 610-616. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8FADB11D7063]
 
La maladie liée aux IgG4: une cause possible d'ictère obstructif [IgG4-related disease: a possible cause of obstructive jaundice].
Moreillon M., Yan P., Buss G., Bart P.A., 2015/04. Revue Médicale Suisse, 11 (469) pp. 813-819. Peer-reviewed.
[Pmid][serval:BIB_18332757AD9F]
 
Artérite de Horton: recommandations Lausannoises de prise en charge [Giant cell arteritis: guidelines of the University Hospital of Lausanne].
Tsetsou S., Michel P., Ribi C., Hirt L., Kawasaki A., Hugli O., De Leval L., Bart P.A., Waeber G., Meuli R. et al., 2015/02. Revue Médicale Suisse, 11 (461) pp. 411-417.
[Pmid][serval:BIB_14E431815FB6]
Combined Use of Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses Is a Powerful Diagnostic Tool of Active Tuberculosis.
Rozot V., Patrizia A., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Ohmiti K., Goletti D. et al., 2015. Clinical Infectious Diseases, 60 (3) pp. 432-437. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35203E0F848B]
 
Déclaration et traitement des événements indésirables en médecine interne [Incident-reporting electronic-based system in internal medicine].
Servet J., Bart P.A., Wasserfallen J.B., Castioni J., 2015. Revue Médicale Suisse, 11 (493) pp. 2076-2080.
[Pmid][serval:BIB_84C940212026]
 
Découverte fortuite d'un déficit en immunoglobulines [Incidental discovery of an immunoglobulin deficiency].
Hungerbühler P., Bart P.A., 2015. Revue Médicale Suisse, 11 (467) pp. 740-741.
[Pmid][serval:BIB_6C37EDAF0DA6]
Identification and visualization of multidimensional antigen-specific T-cell populations in polychromatic cytometry data.
Lin L., Frelinger J., Jiang W., Finak G., Seshadri C., Bart P.A., Pantaleo G., McElrath J., DeRosa S., Gottardo R., 2015. Cytometry. Part A, 87 (7) pp. 675-682. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A190F236B1C2]
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.
Fuchs J.D., Bart P.A., Frahm N., Morgan C., Gilbert P.B., Kochar N., DeRosa S.C., Tomaras G.D., Wagner T.M., Baden L.R. et al., 2015. Journal of Aids and Clinical Research, 6 (5) p. 6. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D222A8F6521D]
2014
 
Health care professional's' attitudes towards bedside case presentations during ward rounds
Gachoud D., Garnier A., Monti M., Bart P.-A., Lamy O., Marques-Vidal P., Vollenweider P., Sartori C., Bonvin R., Villar B. et al., 2014/05. dans European and Swiss congress of Internal Medicine 2014.
[serval:BIB_F43081C4C8DB]
Double seronegative myasthenia gravis with antiphospholipid syndrome: a case report.
Dan D., Bart P.A., Novy J., Kuntzer T., Clair C., 2014. Journal of Medical Case Reports, 8 (1) p. 2. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A6CA332FA6F5]
Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders.
Perreau M., Vigano S., Bellanger F., Pellaton C., Buss G., Comte D., Roger T., Lacabaratz C., Bart P.A., Levy Y. et al., 2014. Journal of Experimental Medicine, 211 (10) pp. 2033-2045. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C2E49D53264]
HIV-1 superinfection with a triple-class drug-resistant strain in a patient successfully controlled with antiretroviral treatment.
Castro E., Zhao H., Cavassini M., Mullins J.I., Pantaleo G., Bart P.A., 2014. Aids, 28 (12) pp. 1840-1844. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A45B5FC5D96]
 
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
Bart P.A., Huang Y., Karuna S.T., Chappuis S., Gaillard J., Kochar N., Shen X., Allen M.A., Ding S., Hural J. et al., 2014. Journal of Clinical Investigation, 124 (11) pp. 4843-4856.
[DOI][WoS][Pmid][serval:BIB_CED7CDA79111]
2013
 
Combined analysis of mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses for the timely diagnosis of active TB disease.
Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day C, Perreau M, Lazor-Blanchet C, Petruciolli E, Hanekom W, Goletti D et al., 2013/04/18., Société Suisse d’allergologie et Société Suisse de penumologie dans Congrès annuel de la Société Suisse d’allergologie et Société Suisse de penumologie / Présentation orale / Laboratory diagnostic / 2013 Bern.
[serval:BIB_03E563DA8898]
 
Biomarqueurs en immunologie générale [Biomarkers in clinical immunology].
Pardon A., Aubert V., Bart P.A., 2013. Revue Médicale Suisse, 9 (404) pp. 1982-1991.
[Pmid][serval:BIB_42627C1CB334]
 
L'année 2012 de la perspective de l'interniste hospitalier [What is new in 2012 for the specialist in hospital internal medicine?].
Pelet E., Gagliano M., Garnier A., Mayor V., Laurent J.C., Gianinazzi F., Hugelshofer S., Fournier J., Rochat M.C., Urbano L.A. et al., 2013/01. Revue Médicale Suisse, 9 (370) pp. 199-202.
[Pmid][serval:BIB_85C504395ECB]
 
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4(+) T cells in active disease.
Perreau M., Rozot V., Welles H.C., Belluti-Enders F., Vigano S., Maillard M., Dorta G., Mazza-Stalder Jesica, Bart P.A., Roger T. et al., 2013. European Journal of Immunology, 43 (4) pp. 939-948.
[DOI][WoS][Pmid][serval:BIB_E956D462F256]
 
Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease.
Rozot V., Vigano S., Mazza-Stalder J., Idrizi E., Day C.L., Perreau M., Lazor-Blanchet C., Petruccioli E., Hanekom W., Goletti D. et al., 2013. European Journal of Immunology, 43 (6) pp. 1568-1577.
[DOI][WoS][Pmid][serval:BIB_7269592AD615]
Polymyalgia rheumatica en 2012.
Buss G., Petitpierre S., Beer D., Zufferey P., Bart P.A., 2013. Forum Médical Suisse, 13 (7) pp. 136-140.
[URN][serval:BIB_0E7ADED9B266]
Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells.
Viganò S., Bellutti Enders F., Miconnet I., Cellerai C., Savoye A.L., Rozot V., Perreau M., Faouzi M., Ohmiti K., Cavassini M. et al., 2013. Plos Pathogens, 9 (7) pp. e1003423.
[URN][DOI][WoS][Pmid][serval:BIB_D20B27FA77D4]
2012
 
Allergie aux beta-lactamines [Allergy to beta-lactam antibiotics].
Comte D., Petitpierre S., Spertini F., Bart P.A., 2012. Revue Médicale Suisse, 8 (337) pp. 836, 838-836, 842.
[Pmid][serval:BIB_3867C9F25CAD]
 
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Schmidt C., Smith C., Barin B., Bakhtyari A., Bart P.A., Bekker L.G., Chomba E., Clumeck N., Ho D., Hoosen A. et al., 2012. Human Vaccines and Immunotherapeutics, 8 (5) pp. 630-638.
[DOI][WoS][Pmid][serval:BIB_3528513AE54B]
 
Immunodéficience commune variable: ce qu'il faut savoir [Common variable immune deficiency: what you need to know].
Buss G., Comte D., Spertini F., Bart P.A., Petitpierre S., 2012. Revue Médicale Suisse, 8 (337) pp. 859-864.
[Pmid][serval:BIB_267159E0AF97]
 
Mycobacterium tuberculosis-specific CD8 T cells are functionally and phenotypically different between latent infection and active disease
Rozot V., Vigano S., Mazza-Stalder J., Perreau M., Goletti D., Bart P. A., Nicod L., Pantaleo G., Harari A., 2012. p. 598 dans European Congress of Immunology, Immunology.
[WoS][serval:BIB_D7303CF13CEC]
 
Nonrandom Distribution of Cryptic Repeating Triplets of Purines and Pyrimidines (RNY)(n) in gp120 of HIV Type1.
De Crignis E., Guglietta S., Foley B.T., Negroni M., Di Narzo A.F., Waelti Da Costa V., Cavassini M., Bart P.A., Pantaleo G., Graziosi C., 2012. Aids Research and Human Retroviruses, 28 (5) pp. 493-504.
[DOI][WoS][Pmid][serval:BIB_E7E373E5CDE0]
 
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Harari A., Rozot V., Cavassini M., Enders F.B., Vigano S., Tapia G., Castro E., Burnet S., Lange J., Moog C. et al., 2012. European Journal of Immunology, 42 (11) pp. 3038-3048.
[DOI][WoS][Pmid][serval:BIB_0D93650C7F77]
 
Syndrome de Sjögren: enfin une nouvelle approche de traitement [Sjögren's syndrome: a new approach to treatment].
Rossier V., Bart P.A., Spertini F., 2012. Revue Médicale Suisse, 8 (337) pp. 843-847.
[Pmid][serval:BIB_1ED13D02C38D]
2011
 
Dominant TNF-α+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease.
Harari A., Rozot V., Bellutti Enders F., Perreau M., Mazza-Stalder J.M., Nicod L.P., Cavassini M., Calandra T., Blanchet C.L., Jaton K. et al., 2011/03. Nature medicine, 17 (3) pp. 372-376. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C47C605FFBCF]
 
Allergie aux venins d'hyménopteres: nouveautés diagnostiques et prise en charge [Hymenoptera venom allergy: new diagnostic tools and management].
Comte D., Petitpierre S., Bart P.A., Spertini F., Leimgruber A., 2011. Revue Médicale Suisse, 7 (291) pp. 844-849.
[Pmid][serval:BIB_4870E9EAE1B3]
 
Allergo-immunologie. 2. Faut-il se méfier des agents biologiques [Allergy-immunology. Do we have to be afraid of biological agents?].
Bart P.A., 2011. Revue Médicale Suisse, 7 (278) pp. 106-107.
[Pmid][serval:BIB_5E2E3F136B15]
 
DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa
Perreau M., Welles H.C., Harari A., Hall O., Martin R., Maillard M., Dorta G., Bart P., Kremer E.J., Tartaglia J. et al., 2011. pp. A3 dans AIDS Vaccine 2011 Conference, Aids Research and Human Retroviruses. Peer-reviewed.
[WoS][serval:BIB_5A1662127306]
 
DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.
Perreau M., Welles H.C., Harari A., Hall O., Martin R., Maillard M., Dorta G., Bart P.A., Kremer E.J., Tartaglia J. et al., 2011. Journal of Virology, 85 (19) pp. 9854-9862.
[DOI][WoS][Pmid][serval:BIB_B8BC78EDCB21]
 
Désensibilisation: vers de nouvelles perspectives [Allergen specific immunotherapy: review of new perspectives].
Gaillard J., Bart P.A., Leimgruber A., Spertini F., 2011. Revue Médicale Suisse, 7 (291) pp. 850-855.
[Pmid][serval:BIB_E14151229D6B]
Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients.
Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., 2011. Clinical Infectious Diseases, 52 (2) pp. 248-256.
[URN][DOI][WoS][Pmid][serval:BIB_7D018B2FD982]
 
Qu'attendre du futur du diagnostic en allergologie [What to expect from allergy tests?].
Spertini F., Leimgruber A., Bart P.A., 2011. Revue Médicale Suisse, 7 (291) pp. 856-859.
[Pmid][serval:BIB_D20F9C200B3C]
 
Randonnée: conseils utiles aux patients (1re partie) [Hiking and useful advices to patients (part 1)].
Labgaa I., Pasche O., Bart P.A., Cornuz J., 2011. Revue Médicale Suisse, 7 (319) pp. 2348-2354.
[Pmid][serval:BIB_FBB47FEBDD26]
2010
 
Atteintes cardiaques dans les connectivites: l'exemple du lupus érythémateux systémique [Cardiac involvement in connective tissue disease: the example of systemic lupus erythematosus]
Chappuis S., Vogt P., Petitpierre S., Leimgruber A., Spertini F., Bart P.A., 2010. Revue Médicale Suisse, 6 (245) pp. 804-811.
[Pmid][serval:BIB_0CB5309EB684]
 
Attention, prévention [Prevention of transmissible diseases].
Seebach J., Bart P.A., Spertini F., 2010. Revue Médicale Suisse, 6 (245) pp. 795-796.
[Pmid][serval:BIB_39CE53B65B7B]
HIV-1 drug resistance transmission networks in southwest Switzerland.
Castro E., Khonkarly M., Ciuffreda D., Bürgisser P., Cavassini M., Yerly S., Pantaleo G., Bart P.A., 2010. Aids Research and Human Retroviruses, 26 (11) pp. 1233-1238. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_07DD24ABA5AA]
 
Modulation of TCR avidity of primary HIV-1-specific CD8 T-cell responses by early and potent antiviral therapy responses
Harari A., Vlgano S., Bellutti Enders F., Cellerai C., Castro E., Cavassini M., Bart P., Pantaleo G., 2010. pp. A7-A8 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.
[WoS][serval:BIB_4ED69DA1DA17]
 
Oesophagite à éosinophiles [Eosinophilic esophagitis].
Odman M., Bart P.A., 2010. Revue Médicale Suisse, 6 (265) pp. 1854-6, 1858.
[Pmid][serval:BIB_8B0EDDB56F91]
 
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens requires 3 DNA injections. Results of the EV03/ANRS Vac20 Phase I/II Trial
Levy Y., Ellefsen K., Stoeehr W., Bart P., Lelievre J., Launay O., Wolf H., Weber J., Chene G., Pantaleo G., 2010. pp. A10 dans AIDS Vaccine 2010, Aids Research And Human Retroviruses. Peer-reviewed.
[WoS][serval:BIB_C3AEE549A46C]
Recommandations de vaccination pour les patients atteints de maladie chronique [Immunization guidelines regarding patients with a chronic disease].
Aubert C., Vaudaux B., Bart P.A., Université de Lausanne, 2010. Revue Médicale Suisse, 6 (245) pp. 798-803.
[URN][Pmid][serval:BIB_7AE570545379]
 
Sarcoïdose extrapulmonaire: entité méconnue [Extrapulmonary sarcoidosis: an unrecognized disease entity?].
Lyko C., Bart P.A., Pruvot E., Prior J., Waeber G., 2010. Revue Médicale Suisse, 6 (269) pp. 2056-2060.
[Pmid][serval:BIB_45B7BD27ED7B]
2009
 
Antigen exposure regulates the balance between proliferating and cytotoxic subsets of virus-specific CD8 T-cells : P16-32
Cellerai C., Perreau M., Rozot V., Enders F. Bellutti , Bart P., Pantaleo G., Harari A., 2009. p. 261 dans AIDS Vaccine 2009, Retrovirology. Peer-reviewed.
[DOI][WoS][serval:BIB_6703D99F50F4]
 
Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.
Mooij P., Balla-Jhagjhoorsingh S.S., Beenhakker N., van Haaften P., Baak I., Nieuwenhuis I.G., Heidari S., Wolf H., Frachette M.J., Bieler K. et al., 2009. Journal of Virology, 83 (11) pp. 5881-5889.
[DOI][WoS][Pmid][serval:BIB_BCE4CC57F51F]
 
Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.
Harari A., Enders F.B., Cellerai C., Bart P.A., Pantaleo G., 2009. Journal of Virology, 83 (7) pp. 2862-2871.
[DOI][WoS][Pmid][serval:BIB_26C61DC56F12]
 
Mastocytose: quand faut-il y penser ? [Mastocytosis: when should it be considered?]
Comte-Perret S., Bart P.A., Spertini F., Leimgruber A., 2009. Revue Médicale Suisse, 5 (199) pp. 837-842.
[Pmid][serval:BIB_779E1372EF6A]
 
Stratégies thérapeutiques dans les myopathies inflammatoires [Therapeutic strategies in idiopatic inflammatory myopathies]
Chakour R., Leimgruber A., Bart P.A., Spertini F., 2009. Revue Médicale Suisse, 5 (199) pp. 812-818.
[Pmid][serval:BIB_AB326BE6548B]
 
Utilité de la recherche des autoanticorps dans la pratique quotidienne [Use of autoantibodies in clinical practice]
Petitpierre S., Aubert V., Leimgruber A., Spertini F., Bart P.A., 2009. Revue Médicale Suisse, 5 (199) pp. 823-831.
[Pmid][serval:BIB_C41A5499B6D0]
2008
 
Allergies alimentaires rares [Rare food allergies]
Bandelier C., Leimgruber A., Wassenberg J., Bart P. A., Spertini F., 2008. Revue Médicale Suisse, 4 (154) pp. 1024-1029.
[Pmid][serval:BIB_9D4C5494C3F0]
 
Allergo-immunologie : 1. Dans quelles situations doit-on penser au syndrome des antiphospholipides? [When should consider antiphospholipid syndrome?]
Bart P. A., 2008. Revue Médicale Suisse, 4 (140) pp. 97-99.
[Pmid][serval:BIB_B601D15580E0]
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Harari A., Bart P. A., Stohr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O., Barber T. et al., 2008. Journal of Experimental Medicine, 205 (1) pp. 63-77. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3CD56A6881FB]
 
EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.
Bart P.A., Goodall R., Barber T., Harari A., Guimaraes-Walker A., Khonkarly M., Sheppard N.C., Bangala Y., Frachette M.J., Wagner R. et al., 2008. Vaccine, 26 (25) pp. 3153-3161. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CB078A5AF88C]
 
EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone.
McCormack S., Stöhr W., Barber T., Bart P.A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M., Gamboni R. et al., 2008. Vaccine, 26 (25) pp. 3162-3174. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6443A01EDC31]
 
Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants
Castro E., Belair M., Rizzardi G. P., Bart P. A., Pantaleo G., Graziosi C., 2008. AIDS Research and Human Retroviruses, 24 (1) pp. 106-113. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_83F70B875C65]
 
Maladie de Behçet: d'Hippocrate aux antagonistes du TNF-alpha
Zuber P.J., Bart P.A., Leimgruber A., Spertini F., 2008. Revue Médicale Suisse, 4 (154) pp. 1045-1054.
[Pmid][serval:BIB_1D4E8F44B8A6]
 
Multiples étiologies de l'angioedème [The multiple etiologies of angioedema]
Petitpierre S., Bart P. A., Spertini F., Leimgruber A., 2008. Revue Médicale Suisse, 4 (154) pp. 1030-1038.
[Pmid][serval:BIB_CE0CE2548A11]
 
Severe occlusive vasculitis as a complication of cat scratch disease
Berguiga M., Abouzeid H., Bart P.A., Guex-Crosier Y., 2008. Klinische Monatsblätter für Augenheilkunde, 225 (5) pp. 486-487. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_11C4266B575C]
2007
 
Severe interference between retinal angiography and automated four-color flow cytometry analysis of blood mononuclear cells
Burgisser P., Vaudaux J., Bart P. A., 2007/08. Cytometry. Part A, 71 (8) pp. 632-6.
[DOI][WoS][Pmid][serval:BIB_7BDDF03C0C67]
 
Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity
Peters B. S., Jaoko W., Vardas E., Panayotakopoulos G., Fast P., Schmidt C., Gilmour J., Bogoshi M., Omosa-Manyonyi G., Dally L. et al., 2007/03. Vaccine, 25 (11) pp. 2120-7.
[DOI][WoS][Pmid][serval:BIB_00D80A63BCAD]
 
Alimentation a l'ere industrielle: les nouveaux risques allergologiques. [Modern nutrition and development of new allergies]
Wassenberg J., Ciuffreda D., Bart P. A., Leimgruber A., Spertini F., 2007. Revue Médicale Suisse, 3 (108) pp. 1032-4, 1036-7.
[Pmid][serval:BIB_E4D73D278F24]
 
Allergo-immunologie. 2. Traitement de l'asthme: une place pour les agents biologiques en 2007? [New trends in asthma therapy: is there a place for biologicals in 2007?]
Bart P. A., 2007/01. Revue Médicale Suisse, 3 (94) pp. 103-6.
[Pmid][serval:BIB_84DCC9D20BBB]
 
Les arterites des grands vaisseaux: maladie de Horton et maladie de Takayasu. [Large vessel vasculitis: giant cell arteritis and Takayasu arteritis]
Petitpierre S., Bart P. A., Leimgruber A., Prior J., Spertini F., 2007. Revue Médicale Suisse, 3 (108) pp. 1056-60, 1062-3.
[Pmid][serval:BIB_D072DD80B728]
2006
 
Clinical proteomics: study of a cryogel
Robert D., Barelli S., Crettaz D., Bart P. A., Schifferli J. A., Betticher D., Tissot J. D., 2006/07. Proteomics, 6 (13) pp. 3958-60.
[DOI][WoS][Pmid][serval:BIB_3016A376D1A8]
 
Molecular defects of the C7 gene in two patients with complement C7 deficiency
Barroso S., Rieubland C., Jose alvarez A., Lopez-Trascasa M., Bart P. A., Nunez-Roldan A., Sanchez B., 2006/06. Immunology, 118 (2) pp. 257-60.
[DOI][WoS][Pmid][serval:BIB_B4BF85B6C45D]
 
Immune-based interventions in HIV infection: doing the right studies, getting the right answers
Bart P. A., Pantaleo G., 2006/02. AIDS, 20 (4) pp. 617-8.
[DOI][WoS][Pmid][serval:BIB_43999594B92F]
 
2. Le phenomene de Raynaud: mieux comprendre pour mieux traiter. [Understanding Raynaud's phenomenon: towards a better treatment]
Bart P. A., Waeber B., 2006/01. Revue Médicale Suisse, 2 (48) pp. 93-6.
[Pmid][serval:BIB_716F8A466316]
 
Clinical studies of experimental vaccines.
Bart P.A., Harari A., Pantaleo G., 2006. Current Opinion in Hiv and Aids, 1 (4) pp. 286-293.
[DOI][WoS][Pmid][serval:BIB_E8922002E905]
 
Functional signatures of protective antiviral T-cell immunity in human virus infections.
Harari A., Dutoit V., Cellerai C., Bart P.A., Du Pasquier R.A., Pantaleo G., 2006. Immunological Reviews, 211 pp. 236-254. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FE2B6D903135]
 
Mécanismes pathogéniques de la sclérodermie et leurs conséquences thérapeutiques. 1ère partie: pathogénie [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 1: pathogenesis]
Zuber J. P., Chizzolini C., Leimgruber A., Bart P. A., Spertini F., 2006. Revue Médicale Suisse, 2 (62) pp. 1052-7.
[Pmid][serval:BIB_A3A4A5BDE446]
 
Mécanismes pathogéniques de la sclérodermie et leurs conséquences thérapeutiques. 2e partie: traitement. [Pathogenic mechanisms in systemic sclerosis and their therapeutical consequences. Part 2: treatment]
Zuber J. P., Chizzolini C., Leimgruber A., Bart P. A., Spertini F., 2006. Revue Médicale Suisse, 2 (62) pp. 1058, 1060-6.
[Pmid][serval:BIB_DA14B2B7C5FC]
2005
 
HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells
Zimmerli S. C., Harari A., Cellerai C., Vallelian F., Bart P. A., Pantaleo G., 2005/05. Proceedings of the National Academy of Sciences of the United States of America, 102 (20) pp. 7239-44.
[DOI][WoS][Pmid][serval:BIB_81FC323D58B8]
 
3. Nouvelles strategies dans le traitement des vasculites associees aux ANCA. [New therapeutic strategies in ANCA-associated systemic vasculitis]
Ruiz F. L., Bart P. A., 2005/01. Revue Médicale Suisse, 1 (1) pp. 19-23.
[Pmid][serval:BIB_BF600F0819D1]
 
Sarcoidose: nouveaux concepts pathogeniques et thera- peutiques pour une (vieille) maladie. [Sarcoidosis: new therapeutic and pathogenic aspects for an "old" disease]
Zuber J. P., Spertini F., Leimgruber A., Bart P. A., 2005. Revue Médicale Suisse, 1 (15) pp. 1026, 1029-34, 1036-8.
[Pmid][serval:BIB_74B0A0EDD847]
 
Syndrome oral croisé et allergies alimentaires [Oral allergy syndrome and food allergy]
Fontana M., Spertini F., Bart P. A., Leimgruber A., 2005. Revue Médicale Suisse, 1 (15) pp. 1010, 1013-7.
[Pmid][serval:BIB_CD22D77F341F]
 
Tests cutanes en allergologie: si simple en apparence... [Skin tests in allergology: really so simple?]
Deruaz C. A., von Feilitzen A., Leimgruber A., Bart P. A., Spertini F., 2005. Revue Médicale Suisse, 1 (15) pp. 997-1002.
[Pmid][serval:BIB_9E708818F2C8]
2004
 
Latex : de l'allergie professionnelle au syndrome latex-fruit
Deruaz C. A., Lapointe A. K., Bart P. A., Leimgruber A., Spertini F., 2004. Médecine et Hygiène, 62 (2471) pp. 421-426.
[serval:BIB_5D827704B0A9]
 
Le syndrome des antiphospholipides
Périard D., Bart P. A., Deruaz C. A., Spertini F., Leimgruber A., 2004. Médecine et Hygiène, 62 (2471) pp. 438-442.
[serval:BIB_33BDEAAFDDBE]
 
Que doit retenir le praticien des immunodéficiences primaires ?
Lurati-Ruiz F., Bart P. A., Hofer M., Périard D., Leimgruber A., Spertini F., 2004. Médecine et Hygiène, 62 (2471) pp. 451-458.
[serval:BIB_3023F66D9410]
 
Vasculites cutanées : leurs implications en immunologie clinique
Lapointe A. K., Leimburger A., Spertini F., Künzle N., Laffitte E., Bart P. A., 2004. Médecine et Hygiène, 62 (2471) pp. 430-436.
[serval:BIB_7F5C1B4B6902]
2003
 
Allergologie et immunologie clinique. Les immunosuppresseurs dans les maladies auto-immunes : nouveautés
Bart P. A., 2003. Médecine et Hygiène, 61 pp. 14-20.
[serval:BIB_F0CB3A8815F3]
 
Approche anti-inflammatoire de la rhinite allergique
Deruaz C., Bart P. A., Spertini F., Leimgruber A., 2003. Médecine et Hygiène, 61 (2433) pp. 836-40.
[serval:BIB_ED0A39BE2BD1]
 
Comment évaluer le risque oncologique d'un patient souffrant de dermatomyosite [Can we predict the risk of malignancy associated with dermatomyositis?]
Gainon J., Bart P.A., Waeber G., 2003. Praxis, 92 (41) pp. 1734-9.
[Pmid][serval:BIB_0FF609A29505]
 
Formation en médecine interne: de l'utilité des "case reports" [Education in internal medicine: usefulness of "case reports"]
Bart P.A., Lamy O., Vollenweider P., Waeber G., 2003. Praxis, 92 (41) pp. 1711-2.
[Pmid][serval:BIB_8FECBEAFA1A6]
 
Insuffisance aortique et artérite de Kakayasu. Abstract P269
Fivaz-Arbane M., Jeanrenaud X., Delabays A., Girod G., Bart P. A., Kappenberger L., 2003. Kardiovaskuläre Medizin, 6 Suppl 5.
[serval:BIB_2F0300B9691E]
 
Intérêt des anticorps anti-cytoplasme des neutrophiles (ANCA) en clinique
Lurati Ruiz F., Leimgruber A., Bart P. A., Spertini F., 2003. Médecine et Hygiène, 61 (2433) pp. 830-834.
[serval:BIB_14490A2CD1F9]
 
Périartérite noueuse et hépatite C: association fortuite [Periarteritis nodosa and hepatitis C: a fortuitous association?]
Zuber J.P., Deruaz C., Lobrinus J.A., Waeber G., Bart P.A., 2003. Praxis, 92 (41) pp. 1717-25.
[Pmid][serval:BIB_539B818AB4DB]
2002
 
Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.
Ellefsen K., Harari A., Champagne P., Bart P.A., Sékaly R.P., Pantaleo G., 2002/12. European journal of immunology, 32 (12) pp. 3756-3764. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_23749]
 
Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection
Harari A., Rizzardi G. P., Ellefsen K., Ciuffreda D., Champagne P., Bart P. A., Kaufmann D., Telenti A., Sahli R., Tambussi G. et al., 2002/08. Blood, 100 (4) pp. 1381-7.
[DOI][WoS][Pmid][serval:BIB_A47337CF723B]
 
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
Rizzardi G. P., Harari A., Capiluppi B., Tambussi G., Ellefsen K., Ciuffreda D., Champagne P., Bart P. A., Chave J. P., Lazzarin A. et al., 2002/03. Journal of Clinical Investigation, 109 (5) pp. 681-8.
[DOI][WoS][Pmid][serval:BIB_8F0AB4D335C7]
2001
 
Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir.
Bart P.A., Rizzardi P.G., Gallant S., Golay K.P., Baumann P., Pantaleo G., Eap C.B., 2001. Therapeutic drug monitoring, 23 (5) pp. 553-5. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5E69B13DE248]
2000
 
Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count
Rizzardi G. P., Tambussi G., Bart P. A., Chapuis A. G., Lazzarin A., Pantaleo G., 2000/10. AIDS, 14 (15) pp. 2257-63.
[DOI][WoS][Pmid][serval:BIB_1BCA2AEDCDC7]
Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA
Rizzardi G. P., De Boer R. J., Hoover S., Tambussi G., Chapuis A., Halkic N., Bart P. A., Miller V., Staszewski S., Notermans D. W. et al., 2000/03. Journal of Clinical Investigation, 105 (6) pp. 777-82. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D4C4AC55EE07]
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy.
Bart P.A., Rizzardi G.P., Tambussi G., Chave J.P., Chapuis A.G., Graziosi C., Corpataux J.M., Halkic N., Meuwly J.Y., Munoz M. et al., 2000. AIDS, 14 (13) pp. 1887-1897. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_93716372A45C]
1999
 
Sampling lymphoid tissue cells by ultrasound-guided fine needle aspiration of lymph nodes in HIV-infected patients. Swiss HIV Cohort Study
Bart P. A., Meuwly J. Y., Corpataux J. M., Yerly S., Rizzardi P., Fleury S., Munoz M., Knabenhans C., Welbon C., Pantaleo G. et al., 1999/08. AIDS, 13 (12) pp. 1503-9.
[DOI][WoS][Pmid][serval:BIB_AF023E65D591]
1998
 
Immunopathogenesis of HIV infection
Graziosi C., Soudeyns H., Rizzardi G. P., Bart P. A., Chapuis A., Pantaleo G., 1998/06. AIDS Research and Human Retroviruses, 14 Suppl 2 pp. S135-42.
[WoS][Pmid][serval:BIB_A974D2764559]
 
Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers
Reutter J., Bart P. A., Francioli P., Safary A., Frei P. C., 1998/05. Journal of Viral Hepatitis, 5 (3) pp. 205-11.
[DOI][WoS][Pmid][serval:BIB_B5FDCFC5499D]
 
Impact des nouveaux concepts pathogéniques de l'infection VIH sur les perspectives thérapeutiques [Impact of new concepts in pathogenesis of HIV infection on future therapeutic perspectives]
Bart P.A., Pantaleo G., 1998. Médecine et Hygiène, 56 (2215) pp. 1374-1377.
[serval:BIB_BE1933356971]
 
Limited CD4+ T-cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy.
Fleury S., de Boer R.J., Rizzardi G.P., Wolthers K.C., Otto S.A., Welbon C.C., Graziosi C., Knabenhans C., Soudeyns H., Bart P.A. et al., 1998. Nature Medicine, 4 (7) pp. 794-801. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B77754D94784]
1996
 
Vaccination chez des patients ages admis en readaptation: opportunites manquees? [Vaccination in elderly patients in rehabilitation: a missed opportunity?]
Bula C. J., Closuit A., Meier-Padel S., Bart P. A., Schluter L., Rossier P., 1996/11. Schweizerische Medizinische Wochenschrift, 126 (48) pp. 2082-6.
[WoS][Pmid][serval:BIB_37D6B3647149]
 
Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery
Bart P. A., Jacquier P., Zuber P. L., Lavanchy D., Frei P. C., 1996/04. Liver, 16 (2) pp. 110-6.
[WoS][Pmid][serval:BIB_311D43250D27]
 
Ostéomyélite à Scedosporium apiospermum chez un patient neutropénique [Scedosporium apiospermum osteomyelitis in a neutropenic patient]
Bart P.A., Greub G., Cometta A., Bille J., 1996. Journal de Mycologie Médicale, 6 (4) pp. 178-181.
[WoS][serval:BIB_7D874A9CB1D0]
 
Séroprévalence de l'hépatite B chez 9000 femmes accouchant en Suisse en 1990-1991
Bart P. A., Frei P. C., 1996. Bulletin de l'Office fédéral de la santé publique, 8 pp. 3-6.
[serval:BIB_1E908812D7A7]
1995
 
Immunization status of elderly patients admitted for rehabilitation.
Bula C.J., Closuit A., Meier-Padel S., Bart P.A., 1995. p. 212 dans 48th Annual Scientific Meeting of the Gerontological Society of America, Gerontologic Challenges : Biological Through Societal Perspectives, Gerontologist.
[serval:BIB_8174E90C9490]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University